Is glycemic variability important to assessing antidiabetes therapies?

Is glycemic variability important to assessing antidiabetes therapies? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Is glycemic variability important to assessing antidiabetes therapies? Abstract Text:

Boris P Kovatchev,

Traditionally, statistical estimation of glycemic variability includes computing standard deviation of glucose readings or related statistics (eg, M value, mean amplitude of glucose excursions, and so forth). We advocate an alternative approach using risk measures of variability, which have substantial clinical and numerical advantages. In addition, continuous glucose monitoring (CGM) data have clinically important inherent temporal structure that should be taken into consideration. Thus, temporal variability methods are discussed for the analysis and interpretation of CGM output.

Is glycemic variability important to assessing antidiabetes therapies? Publishing Authors By Initials

BP Kovatchev,

For similar chemical actions and uses: pharmacologic actions: physiological effects of drugs: hypoglycemic agents research abstracts see: chemical actions and uses: pharmacologic actions: physiological effects of drugs: hypoglycemic agents research

PUBMED ID PMID:

MEDLINE DATE:

Is glycemic variability important to assessing antidiabetes therapies? Journal Published:

PUBLICATION TYPE: Review

Journal: Current diabetes reports

VOLUME: 6

Page Numbers: 350-6

Journal Abbreviation: Curr. Diab. Rep.

ISSN: 1534-4827

DAY: 3

MONTH: Nov

YEAR: 2006

Is glycemic variability important to assessing antidiabetes therapies? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101093791

Is glycemic variability important to assessing antidiabetes therapies? Keywords Mesh Terms:

KEYWORDS: Hypoglycemic Agents

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Is glycemic variability important to assessing antidiabetes therapies? Information

Substance Name: Hypoglycemic Agents

Registry Number: 0

Grant and Affiliation Information for Is glycemic variability important to assessing antidiabetes therapies?

AFFILIATION: University of Virginia Health System, Box 800137, Charlottesville, VA 22908, USA. boris@virginia.edu

Country: United States

AGENCY: United States NIDDK

GRANT: R01 DK 51562

ACRONYM: DK

MEDLINETA: Curr Diab Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Is glycemic variability important to assessing antidiabetes therapies? Related Publications

• Bio-Behavioral Control, Glucose Variability, and Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes (T1DM).
• Driving simulation performance predicts future accidents among older drivers.
• Evaluating Clinical Accuracy of Continuous Glucose Monitoring Systems: Continuous Glucose -Error Grid Analysis (CG-EGA).
• Is glycemic variability important to assessing antidiabetes therapies?
• Manual transmission enhances attention and driving performance of ADHD adolescent males: pilot study.
• Rebound Effects with Long-Acting Amphetamine or Methylphenidate Stimulant Medication Preparations among Adolescent Male Drivers with Attention-Deficit/Hyperactivity Disorder.